3624 results for «2163»
3624 results
TAVI in challenging scenarios: patients with aortic regurgitation
22 Nov 2020 – From PCR Valves e-Course 2020
Discover various cases of TAVI in challenging scenarios: Transfemoral aortic valve implantation in the case of pre-existing mitral prosthesis and pure AR, High-risk patient with severe AR treated with self-expandable TAVI, and more!
TAVI in challenging scenarios: Part 1
22 Nov 2020 – From PCR Valves e-Course 2020
Discover various cases of TAVI in challenging scenarios, such as TAVI with a novel balloon expandable valve for rheumatic AS in a patient with a prosthetic mitral valve, TAVI with a novel pre-packaged self-expandable dry-tissue transcatheter aortic valve, and more!
TAVI complications: Part 1
22 Nov 2020 – From PCR Valves e-Course 2020
Learn how to face various TAVI complications with this selection of cases: post-TAVR cardiovascular collapse, acute LM coronary obstruction following TAVI with balloon expandable valve, Double chimney stent technique during ViV procedure in high-risk coronary obstruction patient, and more!
How the interventional cardiologist should approach patients with a vasculogenic erectile dysfunction?
Watch this roundtable discussion if you want to learn how cardiologist should approach the patients with erectile dysfunction and to see how to treat a patient with ED with Sirolimus Coated Balloon
Innovative solutions to treat diabetic patients
Watch this video if you want to understand the need of dedicated DES for Diabetes Mellitus (DM) patients, to understand and learn the differences of CAD for diabetic compared to non-diabetic patients, to see clinical evidences and results for the treatment of Diabetic patients with DES+...
Basics of peripheral interventions
25 Jun 2020 – From PCR e-Course 2020
Learn more about how to deal with a complex cross over, how to treat a long superficial femoral artery occlusion and how to decide which material to use after POBA in long SFA occlusive disease.
This session was originally presented during PCR e-Course 2020.
TAVI: Full one-year Evolut low-risk randomised results and economic implications
EVOLUT Low Risk Trial of self-expanding TAVI versus SAVR: discover the key take-aways from the economic analysis as well as the health economics implications to understand the potential drivers for TAVI cost-effectives in Europe.
Videos included on this page: the Hot Line presentation and an Investigator Perspective.
TAVI for bicuspid valves with Evolut: BIVOLUT-X registry
Learn more about transcatheter treatment of bicuspid aortic valves with the EVOLUT platform, the BIVOLUT-X registry design, and key outcomes and practical implications of the study.
Videos included on this page: the Hot Line presentation and an Investigator Perspective.
SYNERGY MEGATRON - Transforming your left main bifurcation strategy for improved outcomes
Watch this session if you want to review steps for PCI in complex left main bifurcation lesions, to advance your knowledge on IVUS-guided PCI in left main disease and to learn about a purpose-built new stent platform for large vessels and left main.
Mastering complex calcified aortic stenosis
Watch this session if you want to advance your knowledge in imaging assessment of complex calcified aortic stenosis and to learn about device selection and implantation technique in calcified anatomies.
Low risk TAVI trials in the real world: where are we in 2020?
26 Jun 2020 – From PCR e-Course 2020
Watch this case discussion if you want to fully appreciate the impact of the low risk TAVI trials, to understand how to apply this information in your daily clinical practice and to translate clinical trial outcomes into real-world decisions by your Heart Team.
This session was originally...
Best real-world applications of Shockwave intravascular lithotripsy (IVL) in coronary calcium
25 Jun 2020 – From PCR e-Course 2020
Watch this session if you want to understand how intravascular lithotripsy works through real-world cases, to hear from global leading physicians about where intravascular lithotripsy fits into their clinical practice and to hear about some of the most prominent cases of coronary intravascular lithotripsy.
Target all comers 3-year results - Evaluation of Cobalt Chrome Rapamycin Drug Eluting Stent
25 Jun 2020 – From PCR e-Course 2020
Watch this session if you want to review the Firehawk family TES technology and early clinical outcomes in the treatment of atherosclerotic lesions, to gain the first sight of the 3-year results of the TARGET AC trial and to look into the Future Directions of Target...
Crossover results from the RADIANCE-HTN SOLO trial
26 Jun 2020 – From PCR e-Course 2020
Watch this session if you want to learn about latest results from RADIANCE-HTN SOLO cohort and to review blood pressure results following crossover to ultrasound RDN in patients originally randomised to the sham arm in RADIANCE-HTN SOLO.
Videos included on this page: the Hot Line presentation, an...
Update on the regulation of high-risk medical devices: a transatlantic perspective
25 Jun 2020 – From PCR e-Course 2020
Watch this session if you want to get an update on new developments in the regulation of high-risk medical devices in Europe and the USA and to learn about opportunities for physicians to become more involved in the regulatory environment.
This session was originally presented during PCR...
Paclitaxel DCB for coronary lesions: 12-month results. Do drug-coated balloons PREVAIL?
25 Jun 2020 – From PCR e-Course 2020
Consult this abstract to discover the PREVAIL trial results and the implications for drug-coated balloons in percutaneous coronary intervention.
Videos included on this page: the abstract presentation and an Investigator Perspective.
PICSO improves coronary microvascular function in patients with STEMI
25 Jun 2020 – From PCR e-Course 2020
Watch this video if you want to learn about the latest OxAMI-PiCSO study clinical results and to learn about the first-in-man of PiCSO in inferior STEMI patients.
Videos included on this page: the Hot Line presentation, an Investigator Perspective and a Wrap Up discussion.
New TMVI therapy to eliminate mitral regurgitation. Evidence and patient selection
26 Jun 2020 – From PCR e-Course 2020
Watch this video if you want to get the latest update on the first commercially available TMVI therapy (Tendyne), to learn about Tendyne clinical experience and how to identify the best candidates for this novel therapy.
Two-year outcomes of Tendyne Transcatheter Mitral Valve Implementation (TMVI) to treat symptomatic severe mitral regurgitation
Learn more about the 2-year outcomes of the first 100 patients treated as part of the Tendyne Expanded Clinical Study, and how the latest Tendyne clinical evidence may change the way the heart team treats mitral regurgitation.
Videos included on this page: the Hot Line presentation and...
Shaping care pathways for severe aortic stenosis patients in a COVID-19 context
Watch this roundtable discussion on the management of aortic stenosis in the context of the COVID-19 pandemic and how to readdress the treatment options and pathways to serve the needs of the patients in this difficult global crisis.
